DK1254209T3 - Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab - Google Patents

Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Info

Publication number
DK1254209T3
DK1254209T3 DK01977759T DK01977759T DK1254209T3 DK 1254209 T3 DK1254209 T3 DK 1254209T3 DK 01977759 T DK01977759 T DK 01977759T DK 01977759 T DK01977759 T DK 01977759T DK 1254209 T3 DK1254209 T3 DK 1254209T3
Authority
DK
Denmark
Prior art keywords
garcinol
anthocyanin
composition
hca
reduction
Prior art date
Application number
DK01977759T
Other languages
Danish (da)
English (en)
Inventor
Muhammed Majeed
Vladimir Badmaev
Original Assignee
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sabinsa Corp filed Critical Sabinsa Corp
Application granted granted Critical
Publication of DK1254209T3 publication Critical patent/DK1254209T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
DK01977759T 2000-08-17 2001-08-17 Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab DK1254209T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22582100P 2000-08-17 2000-08-17

Publications (1)

Publication Number Publication Date
DK1254209T3 true DK1254209T3 (da) 2006-07-24

Family

ID=22846386

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01977759T DK1254209T3 (da) 2000-08-17 2001-08-17 Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab

Country Status (12)

Country Link
US (1) US7063861B2 (de)
EP (1) EP1254209B1 (de)
JP (2) JP4205943B2 (de)
AT (1) ATE320248T1 (de)
AU (1) AU773081B2 (de)
CA (1) CA2387548A1 (de)
DE (1) DE60118019T2 (de)
DK (1) DK1254209T3 (de)
ES (1) ES2260293T3 (de)
NZ (1) NZ518116A (de)
PT (1) PT1254209E (de)
WO (1) WO2002014477A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1254209B1 (de) * 2000-08-17 2006-03-15 Sabinsa Corporation Zusammensetzung enthaltend hydroxyzitronensäure und garcinol zur gewichtsreduzierung
US20030187055A1 (en) * 2002-02-25 2003-10-02 Riker Donald K. Synergistic pharmaceutical combinations for treating obesity
WO2003092730A1 (en) * 2002-04-30 2003-11-13 Unibar Corporation Hydroxycitric acid salt composition and method of making
US8394856B2 (en) * 2002-07-02 2013-03-12 Glykon Technologies Group, Llc (-)-Hydroxycitric acid for controlling inflammation
JP2007502331A (ja) * 2003-05-29 2007-02-08 グリュコン テクノロジーズ グループ エルエルシー （−）−ヒドロキシクエン酸を安定して制御送達するための方法および組成物
US7261769B2 (en) 2003-07-03 2007-08-28 Unibar Corporation Stabilized anthocyanin extract from Garcinia indica
US20050009919A1 (en) * 2003-07-07 2005-01-13 Clouatre Dallas L. Treating cachexia and excessive catabolism with (-)-hydroxycitric acid
US20080207952A1 (en) * 2003-10-09 2008-08-28 Muhammed Majeed Novel therapeutic applications of natural poly isoprenylated benzophenone derivatives as drugs/medicaments
US7386111B2 (en) * 2004-02-10 2008-06-10 Vonage Network Inc. Method and apparatus for placing a long distance call based on a virtual phone number
WO2005117608A1 (en) 2004-06-04 2005-12-15 Horizon Science Pty Ltd Natural sweetener
EP1885453A4 (de) * 2005-06-03 2011-06-29 Horizon Science Pty Ltd Substanzen mit körpermasse-umverteilungseigenschaften
CN104323268A (zh) 2006-09-19 2015-02-04 视界科技有限公司 从甘蔗中获得的提取物及其生产方法
WO2008049121A2 (en) * 2006-10-19 2008-04-24 Renaissance Herbs, Inc. Hydroxycitric acid compositions, methods of making, and therapeutic uses of same
JP2010526043A (ja) * 2007-05-04 2010-07-29 ニュートラスーティック イーティ ビジネス コンサルティング 脂肪分解活性を有する化合物、その取得方法および利用方法
JP5117762B2 (ja) * 2007-05-18 2013-01-16 株式会社半導体エネルギー研究所 液晶表示装置
US20090062231A1 (en) * 2007-08-31 2009-03-05 O'mara Ann Marie Appetite Suppressant Composition and Method of Appetite Suppression
US20100233306A1 (en) * 2009-03-16 2010-09-16 Sevanti Mehta Methods and compositions for weight loss using garcinia indica fruit puree
US20130281544A1 (en) * 2010-12-30 2013-10-24 Muhammed Majeed Hepatoprotectant activity of garcinol
US8329743B2 (en) * 2011-01-10 2012-12-11 Sami Labs Limited Compositions and its use in treating obesity or inducing weight loss
WO2012106761A1 (en) 2011-02-08 2012-08-16 Horizon Science Pty Ltd Sugar extracts
WO2014032100A1 (en) 2012-08-28 2014-03-06 Phytolin Pty Ltd Extraction method
AU2014306366B9 (en) 2013-08-16 2020-03-26 Poly Gain Pte Ltd Sugar cane derived extracts and methods of treatment
US10285961B2 (en) 2014-02-06 2019-05-14 University Of Houston System Organic acids as agents to dissolve calcium minerals in pathological calcification and uses thereof
KR101781365B1 (ko) * 2016-08-31 2017-09-25 주식회사 코씨드바이오팜 반응표면분석법을 이용하여 가르시니아 캄보지아로부터 하이드록시 시트르산을 고수율로 추출하는 방법
MX2019014841A (es) * 2017-06-15 2020-02-17 Sami Labs Ltd Potencial antiobsesidad del garcinol.
US11052125B2 (en) * 2018-04-30 2021-07-06 Sami Labs Limited Compositions for weight loss
GB2623571A (en) * 2022-10-21 2024-04-24 Mootral Innovations Ltd Compositions for reducing methane emission

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
WO1997023210A1 (fr) 1995-12-26 1997-07-03 Suntory Limited Agent anti-obesite dont le principe actif est la procyanidine
JPH10203968A (ja) * 1997-01-27 1998-08-04 Munekazu Iinuma 抗腫瘍剤
JPH10265397A (ja) * 1997-03-25 1998-10-06 Toyotama Kenko Shokuhin Kk 肥満予防剤
JPH111431A (ja) * 1997-06-10 1999-01-06 Nichiyaku Kk 肥満抑制剤
JPH11139965A (ja) * 1997-11-06 1999-05-25 Kikkoman Corp 抗腫瘍薬
JP2000044468A (ja) * 1998-07-29 2000-02-15 Kikkoman Corp リパーゼ阻害剤及び抗肥満剤又は高脂血症抑制剤
JP2000072665A (ja) * 1998-08-31 2000-03-07 Kikkoman Corp ヒアルロニダーゼ阻害剤
AU5802499A (en) 1998-09-01 2000-03-21 Amway Corporation Diet composition and method of weight management
FR2790645B1 (fr) 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
JP2000355536A (ja) * 1999-06-10 2000-12-26 Kikkoman Corp 発癌予防薬
FR2804319B1 (fr) * 2000-01-28 2002-10-25 Clarins Lab Composition cosmetique amincissante comprenant en tant qu'agent actif un extrait de plante contenant de l'anp
EP1254209B1 (de) * 2000-08-17 2006-03-15 Sabinsa Corporation Zusammensetzung enthaltend hydroxyzitronensäure und garcinol zur gewichtsreduzierung

Also Published As

Publication number Publication date
US20020187943A1 (en) 2002-12-12
WO2002014477A3 (en) 2002-08-01
EP1254209B1 (de) 2006-03-15
DE60118019D1 (de) 2006-05-11
PT1254209E (pt) 2006-08-31
EP1254209A2 (de) 2002-11-06
JP2008110996A (ja) 2008-05-15
AU773081B2 (en) 2004-05-13
DE60118019T2 (de) 2006-11-02
US7063861B2 (en) 2006-06-20
WO2002014477A2 (en) 2002-02-21
ATE320248T1 (de) 2006-04-15
ES2260293T3 (es) 2006-11-01
AU9685101A (en) 2002-02-25
NZ518116A (en) 2005-06-24
EP1254209A4 (de) 2004-09-08
JP4205943B2 (ja) 2009-01-07
CA2387548A1 (en) 2002-02-21
JP2004506657A (ja) 2004-03-04

Similar Documents

Publication Publication Date Title
DK1254209T3 (da) Sammensætning omfattende hydroxycitronsyre og garcinol til vægttab
DE60209504D1 (de) Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
TW200633695A (en) Methods for purifying trans-(-)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
TW200600092A (en) Topical slimming preparation and a cosmetic containing a carnitine derivative
ATE506059T1 (de) Therapie zur behandlung der überaktiven blase
BR0317149A (pt) Métodos para uso de uma composição para bebidas
CY1105930T1 (el) Χρηση αναστολεων c-kit για θepαπεια ασθενειων φλεγμονωδους εντερου (ibd)
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
DE60230961D1 (de) Verwendung einer dihydrochalcon-reichen phenolischen Fraktion für eine kosmetische Behandlung
DE69703820D1 (de) Diaromatische propynyl- oder dienylverbindungen
BR0008865A (pt) Composições contendo fluoreto estanhoso para o tratamento de dentes hipersensìveis
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
BRPI0418854A (pt) composições herbáceas
TW200501973A (en) Method of improvement of blood circulation
DE50210605D1 (de) Gewürzkrautzubereitung
RU2673075C1 (ru) Защитный крем для участков кожи с ограниченным воздухообменом